Brett-Smith Helena 4
4 · Trevi Therapeutics, Inc. · Filed Feb 18, 2020
Insider Transaction Report
Form 4
Brett-Smith Helena
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-13+30,000→ 30,000 totalExercise: $5.50Exp: 2030-02-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 13, 2020. The 30,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 13, 2021 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 13, 2024.